{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:11:07Z","timestamp":1793034667404,"version":"4.5.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,18]]},"abstract":"<jats:p>To investigate the supplementary value of the neutrophil-to-lymphocyte ratio (NLR) in diagnosing rheumatoid arthritis (RA) and assessing disease activity, particularly in seronegative RA. This retrospective single-center study included 304 patients from the Department of Rheumatology and Immunology at a tertiary hospital between February 2021 and February 2024. The RA group consisted of 201 patients, and the non-RA control group had 103 patients. Demographic characteristics, blood tests, inflammatory markers (C-reactive protein, erythrocyte sedimentation rate), autoantibodies (rheumatoid factor, anti-cyclic citrullinated peptide antibody), and clinical evaluation data (Disease Activity Score in 28 Joints score) were collected. Multivariate logistic and ordinal logistic regression analyses were performed to identify RA-related factors. The combined diagnostic benefit of NLR was assessed using area under the receiver operating characteristic curve (AUC), net reclassification improvement, and integrated discrimination improvement. Among the 304 subjects, 201 were RA patients (mean age 52.3\u2005\u00b1\u200511.8 yr, 78.6% female) and 103 were non-RA controls (mean age 50.6\u2005\u00b1\u200510.2 yr, 73.8% female). The NLR in the RA group was significantly higher than in the non-RA group (3.2 [2.1\u20134.8] vs 1.8 [1.2\u20132.3], <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). Multivariate regression analysis showed that NLR was an independent predictor for RA diagnosis (odds ratio\u2005=\u20052.15, 95% confidence interval: 1.62\u20132.85, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), with better diagnostic performance than C-reactive protein and erythrocyte sedimentation rate. In seronegative RA patients, NLR remained significantly diagnostic (odds ratio\u2005=\u20052.01, 95% confidence interval: 1.20\u20133.37, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.008). NLR positively correlated with disease activity and was higher in moderate-to-high activity patients (4.2 [3.2\u20135.5], <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). Incremental analysis showed that NLR improved model performance: in the RA population, AUC increased from 0.89 to 0.94 (\u0394AUC\u2005=\u20050.05, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), and in seronegative RA, AUC increased from 0.72 to 0.82 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.002). For disease activity prediction, AUC increased from 0.85 to 0.91 (\u0394AUC\u2005=\u20050.06, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.004), with significant improvements in net reclassification improvement and integrated discrimination improvement (0.18 and 0.07, respectively). NLR is an independent predictor for diagnosing RA and assessing disease activity, particularly in seronegative RA. It enhances diagnostic sensitivity and model discriminative ability and should be promoted as a key inflammatory biomarker for early RA diagnosis.<\/jats:p>","DOI":"10.1097\/md.0000000000043048","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:00:57Z","timestamp":1753156857000},"page":"e43048","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["The supplementary value of the neutrophil-to-lymphocyte ratio in the diagnosis of rheumatoid arthritis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5186-8162","authenticated-orcid":false,"given":"Xiaolan","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Chengdu Wuhou Huanya Huakang Medical Examination Center, Chengdu, Sichuan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250722","first-page":"591","article-title":"Global epidemiology of rheumatoid arthritis.","volume":"18","author":"Finckh","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"R2-20250722","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021.","volume":"5","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"R3-20250722","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/rheumatology\/keaf058","article-title":"Anti-citrullinated procollagen C-endopeptidase enhancer antibody: a potential biomarker for seronegative rheumatoid arthritis.","volume":"64","author":"Lin","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"R4-20250722","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1093\/rheumatology\/keae596","article-title":"High serum levels of CXCL13 predict lower response to csDMARDs in both ACPA-positive and ACPA-negative early rheumatoid arthritis.","volume":"64","author":"De Stefano","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"R5-20250722","first-page":"e63652","article-title":"Anti-carbamylated protein antibodies positivity in rheumatoid arthritis and its association with rheumatoid factor and anti-cyclic citrullinated protein antibodies.","volume":"16","author":"Balaji","year":"2024","journal-title":"Cureus"},{"key":"R6-20250722","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1134\/S1607672924700960","article-title":"Anti-carbamylated protein antibodies in ACPA-negative and ACPA-positive patients with rheumatoid arthritis.","volume":"517","author":"Dibrov","year":"2024","journal-title":"Dokl Biochem Biophys"},{"key":"R7-20250722","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4103\/mgr.MEDGASRES-D-24-00122","article-title":"The inflammatory markers MHR and NLR are independent risk factors for adverse events during hospitalization in older adult patients with myocardial injury caused by acute carbon monoxide poisoning: a retrospective cross-sectional study.","volume":"15","author":"Zhang","year":"2025","journal-title":"Med Gas Res"},{"key":"R8-20250722","doi-asserted-by":"crossref","first-page":"1512621","DOI":"10.3389\/fendo.2025.1512621","article-title":"Association between neutrophil-lymphocyte ratio and all-cause and cardiovascular mortality in patients with diabetes or prediabetes with comorbid obstructive sleep apnea symptoms: evidence from NHANES 2005\u20132008 and 2015\u20132018.","volume":"16","author":"He","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R9-20250722","first-page":"123","article-title":"Association between neutrophil-lymphocyte ratio levels and mortality related to cardiovascular cause and all causes in coronary artery disease patients with low-density lipoprotein cholesterol below 1.4 mmol\/L: a multicenter cohort study.","volume":"35","author":"Jiang","year":"2025","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R10-20250722","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1186\/s12885-025-14060-9","article-title":"Peripheral blood inflammatory biomarkers neutrophil\/lymphocyte ratio, platelet\/lymphocyte ratio and systemic immune-inflammation index\/albumin ratio predict prognosis and efficacy in non-small cell lung cancer patients receiving immunotherapy and opioids.","volume":"25","author":"Lei","year":"2025","journal-title":"BMC Cancer"},{"key":"R11-20250722","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3390\/diagnostics15070834","article-title":"Serum Maresin-1 and Resolvin-D1 levels as non-invasive biomarkers for monitoring disease activity in ulcerative colitis.","volume":"15","author":"Demirci","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"R12-20250722","doi-asserted-by":"crossref","first-page":"1505615","DOI":"10.3389\/fimmu.2024.1505615","article-title":"High cumulative glucocorticoid dose is associated with increased levels of inflammation-related mediators in active rheumatoid arthritis.","volume":"15","author":"Petrackova","year":"2024","journal-title":"Front Immunol"},{"key":"R13-20250722","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s41927-024-00444-0","article-title":"Evaluation of hematological markers as prognostic tools in rheumatoid arthritis.","volume":"8","author":"Masoumi","year":"2024","journal-title":"BMC Rheumatol"},{"key":"R14-20250722","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.62347\/JPNV8527","article-title":"Neutrophil-to-lymphocyte ratio combined with albumin to globulin ratio for predicting rheumatoid arthritis-associated pneumonia.","volume":"16","author":"Duan","year":"2024","journal-title":"Am J Transl Res"},{"key":"R15-20250722","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.freeradbiomed.2025.03.035","article-title":"Urinary total superoxide dismutase activity is low in rheumatoid patients, and its low levels are associated with higher DAS28 scores.","volume":"233","author":"Kor","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"R16-20250722","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.3390\/jcm12247611","article-title":"Correlation of hematological indices and acute-phase reactants in rheumatoid arthritis patients on disease-modifying antirheumatic drugs: a retrospective cohort analysis.","volume":"12","author":"Pan","year":"2023","journal-title":"J Clin Med"},{"key":"R17-20250722","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1111\/1756-185X.13400","article-title":"Relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and disease activity in rheumatoid arthritis treated with rituximab.","volume":"21","author":"Sargin","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"R18-20250722","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.semarthrit.2019.05.008","article-title":"The neutrophil-lymphocyte ratio in early rheumatoid arthritis and its ability to predict subsequent failure of triple therapy.","volume":"49","author":"Boulos","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"R19-20250722","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/jcla.21908","article-title":"The association between neutrophil\/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis.","volume":"30","author":"Mercan","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"R20-20250722","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13075-025-03557-0","article-title":"Divergent gene signatures and neutrophil enrichment in lymph nodes of inflammatory arthritis patients.","volume":"27","author":"O\u2019Byrne","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"R21-20250722","doi-asserted-by":"crossref","first-page":"1565133","DOI":"10.3389\/fimmu.2025.1565133","article-title":"Restoring immune tolerance in pre-RA: immunometabolic dialogue between gut microbiota and regulatory T cells.","volume":"16","author":"Gao","year":"2025","journal-title":"Front Immunol"},{"key":"R22-20250722","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s10020-022-00563-9","article-title":"SIGIRR deficiency contributes to CD4 T cell abnormalities by facilitating the IL1\/C\/EBP\u03b2\/TNF-\u03b1 signaling axis in rheumatoid arthritis.","volume":"28","author":"Teng","year":"2022","journal-title":"Mol Med"},{"key":"R23-20250722","article-title":"Blood biomarker-based predictive indicator for liver metastasis in alpha-fetoprotein-producing gastric cancer and multi-omics tumor microenvironment insights [published online ahead of print May 28, 2025].","author":"Ding","journal-title":"Adv Sci (Weinh)"},{"key":"R24-20250722","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41598-020-79431-7","article-title":"Neutrophil-to-lymphocyte ratio and mortality in the United States general population.","volume":"11","author":"Song","year":"2021","journal-title":"Sci Rep"},{"key":"R25-20250722","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12890-025-03644-7","article-title":"Prevalence and clinical significance of anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis-associated interstitial lung disease.","volume":"25","author":"Huang","year":"2025","journal-title":"BMC Pulm Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:01:00Z","timestamp":1753156860000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":25,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043048","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]}}}